Search Results - "Billmyer, Emma"

Burden of Illness and Treatment Patterns Among Patients With von Willebrand Disease in US Clinical Practice by Swallow, Elyse, Marden, Jessica R., Billmyer, Emma, Yim, Erica, Sun, Shawn X.

“…In this retrospective cohort study, data from an integrated US healthcare system containing both electronic medical record data and linked claims data (from…”
Get full text

Real-world treatment of patients with severe congenital protein C deficiency with protein C concentrate: A physician survey by Wang, Michael, Hertfelder, Hans-Jörg, Swallow, Elyse, Greatsinger, Alexandra, Billmyer, Emma, Fung, Samson, Turecek, Peter L., Gazda, Hanna T., Siffel, Csaba

“…Replacement therapy with intravenous (IV) protein C concentrate (Ceprotin®; Baxalta US Inc., a Takeda company, Lexington, MA, USA; Takeda Manufacturing Austria…”
Get full text

Risk of Thromboembolic Events and Associated Risk Factors, Including Treatments, in Patients with Immune-mediated Diseases by Setyawan, Juliana, Mu, Fan, Yarur, Andres, Zichlin, Miriam L., Yang, Hongbo, Fernan, Catherine, Billmyer, Emma, Downes, Nathaniel, Azimi, Nassir, Strand, Vibeke

“…This study assessed the association between thromboembolic events (TEs) and immune-mediated diseases (IMDs) and characterized the risk profile of TEs among…”
Get full text

Maralixibat Treatment Response in Alagille Syndrome is Associated with Improved Health-Related Quality of Life by Kamath, Binita M., Goldstein, Andrea, Howard, Robin, Garner, Will, Vig, Pamela, Marden, Jessica R., Billmyer, Emma, Anderson, Annika, Kirson, Noam, Jacquemin, Emmanuel, Gonzales, Emmanuel

“…The objective of this study was to assess the impact of treatment response to the ileal bile acid transporter inhibitor maralixibat on health-related quality…”
Get full text

Fr550 THE ECONOMIC BURDEN OF THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE by Yarur, Andres, Mu, Fan, Zichlin, Miriam L., Billmyer, Emma, Downes, Nathaniel, Yang, Hongbo, Azimi, Nassir, Setyawan, Juliana, Strand, Vibeke

Get full text

S0655 The Incremental Rate of Thromboembolic Events in Patients With Inflammatory Bowel Disease Compared to Patients Without Immune-Mediated Diseases by Yarur, Andres, Setyawan, Juliana, Mu, Fan, Zichlin, Miriam L., Fernan, Catherine, Billmyer, Emma, Downes, Nathaniel, Yang, Hongbo, Azimi, Nassir

Get full text

Effect of Delaying High School Start Time on Teen Physical Activity, Screen Use, and Sports and Extracurricular Activity Participation: Results From START by Berger, Aaron T., Erickson, Darin J., Johnson, Kayla T., Billmyer, Emma, Wahlstrom, Kyla, Laska, Melissa N., Widome, Rachel

“…We aimed to characterize relationships between delayed high school start time policy, which is known to lengthen school night sleep duration, and patterns in…”
Get full text

S0656 Risk Factors for Thromboembolic Events Among Patients With Immune-Mediated Diseases by Yarur, Andres, Mu, Fan, Setyawan, Juliana, Zichlin, Miriam L., Yang, Hongbo, Fernan, Catherine, Billmyer, Emma, Downes, Nathaniel, Azimi, Nassir, Strand, Vibeke

Get full text

Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease by Setyawan, Juliana, Mu, Fan, Zichlin, Miriam L., Billmyer, Emma, Downes, Nathaniel, Yang, Hongbo, Azimi, Nassir, Strand, Vibeke, Yarur, Andres

“…Introduction Inflammatory bowel disease (IBD) is associated with greater risk of thromboembolic events (TEs) due to the link between systemic inflammation and…”
Get full text

Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar Gel) for nephrotic syndrome by Rice, J. Bradford, Panaccio, Mary P., White, Alan, Simes, Mark, Billmyer, Emma, Downes, Nathaniel, Niewoehner, John, Wan, George J.

“…Repository corticotropin injection (RCI; Acthar Gel) is indicated to induce a diuresis or a remission of proteinuria in nephrotic syndrome (NS) without uremia…”
Get full text

The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States by Woolley, Michael, Cook, Erin E., Mu, Fan, Betts, Keith A., Billmyer, Emma, Yim, Erica, Chen, Jingyi, Wu, Eric Q.

“…Introduction Eosinophilic gastritis and eosinophilic enteritis (EoG/EoN) are associated with a substantial clinical burden. However, limited information is…”
Get full text

Post-Discharge Outcomes Among Hyperkalemic Patients Treated with and Without Sodium Polystyrene Sulfonate in the Inpatient Setting: PO1445 by Davis, Jill, Israni, Rubeen K., Cook, Erin, Mu, Fan, Betts, Keith, Anzalone, Deborah A., Billmyer, Emma, Lemus Wirtz, Esteban J., Yin, Lei, Szerlip, Harold M., Uwaifo, Gabriel I., Fonseca, Vivian A.

Get full text

Assessment of Work Loss Associated With Prescription-Related Opioid Use Disorder: A Retrospective Analysis of Claims Data by White, Alan G., Spittle, Tim, Fernan, Catherine, Billmyer, Emma, Marrett, Elizabeth, Kwong, Winghan Jacqueline, Rossiter, Louis F.

“…Quantify work loss and costs associated with prescription opioid use disorder (OUD) from the employer perspective. Retrospective claims analysis to compare…”
Get full text

The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases by Setyawan, Juliana, Billmyer, Emma, Mu, Fan, Yarur, Andres, Zichlin, Miriam L., Yang, Hongbo, Downes, Nathaniel, Azimi, Nassir, Strand, Vibeke

“…Introduction Thromboembolic events (TEs) are associated with considerable costs. However, there is a paucity of evidence quantifying the economic burden…”
Get full text

863. Pre-Exposure Prophylaxis (PrEP) Prescriptions among Individuals at High Risk for HIV in the United States, 2012-2018 by Zhou, Mo, Song, Yan, Gao, Emily, Whiteside, Yohance, Billmyer, Emma, Signorovitch, James

Get full text

Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis by Rice, J. Bradford, Panaccio, Mary P., White, Alan, Simes, Mark, Billmyer, Emma, Downes, Nathaniel, Niewoehner, John, Wan, George J.

“…Introduction Repository corticotropin injection (RCI; Acthar ® Gel) is indicated for the treatment of acute exacerbations of multiple sclerosis (MS) in adults…”
Get full text